Skip to content
  • Home
  • JMO Companion App
YouTube Facebook LinkedIn
YouTube Facebook LinkedIn
  • JMO Companion App
Teaching for ImpactTeaching for Impact
  • Programs
    • VCE Program (RESET)
    • Medicine Program
      • Pre-Clinical Lecture Series
      • OSCE Video Series
      • A3 Tutorials
      • Virtual Ward Round Series
      • Clinical Skills Booklet
    • HSC Program
  • Discover
    • Volunteer
Volunteer
Teaching for ImpactTeaching for Impact
Popular Search heart failurehypertensionpneumothoraxhypernatrehypernat

Skills

  • Approach to MET call
  • Indwelling catheter
  • Basic Life Support (BLS) – Adults

Cardiology

  • Acute coronary syndrome
  • Ventricular tachycardia
  • Supraventricular tachycardia
  • Bradycardia
  • Chest pain
  • Heart failure
  • Hypertension

Endocrinology

  • Hypophosphataemia
  • Hypoglycaemia
  • Diabetic ketoacidosis and hyperosmolar hyperglycaemic state
  • Vitamin D deficiency
  • Hypernatremia
  • Hypokalaemia
  • Hyperkalaemia
  • Hypercalcaemia
  • Hyperglycaemia
  • Hypocalcaemia

Urology

  • Haematuria

Palliative care

  • End-of-Life Care

Neurology

  • Acute drop in GCS
  • Vertigo
  • Headache

Respiratory

  • Pneumonia
  • COPD exacerbation
  • Hypoxia
  • Asthma exacerbation
  • Pneumothorax

Geriatrics

  • Falls

Infectious diseases

  • Urinary tract infection
  • Febrile neutropenia
  • Positive blood cultures
  • Cellulitis

Emergency

  • Epistaxis

Gastroenterology

  • Abdominal pain
  • Refeeding syndrome
  • Nausea and vomiting

Haematology

  • Oral Anticoagulants Dosing 

Nephrology

  • Oliguria

General medicine

  • Hypotension
  • Alcohol withdrawal
  • Fluids
  • Delirium
  • Home
  • jmocompanion
  • Infectious diseases
  • Febrile neutropenia

Febrile neutropenia

Table of Contents
  • Overview
  • Triage
  • Causes
  • Clinical Features 
  • Diagnosis
  • Investigations
  • Management [5,6,7]
  • Management - first fever & haemodynamically stable  [5,6,7]
  • Management - first fever & haemodynamically unstable  [5,6,7]
  • Management - subsequent fevers [5,7]
  • References

Overview #

Febrile neutropenia is a medical emergency with high mortality rate if not treated with prompt empiric IV antibiotics. It is commonly seen in patients on haematology or oncology wards who have recently had chemotherapy. Have a low threshold to discuss with the unit registrar or call a MET call if concerned.

Key points

  • Empiric IV antibiotics WITHIN 30 MINUTES of fever onset
  • Take at least two sets of blood cultures prior to commencing antibiotics
  • Notify unit registrar promptly if first febrile episode, haemodynamically unstable or any clinical change/concerns

Triage #

Emergency requiring immediate attention

Causes #

Majority are due to infection – consider both common infections and those specific to the immunocompromised. 

Infective (majority) [1]

  • Unknown source (70-80%)
    • Majority assumed due to chemotherapy induced mucositis and spread of endogenous flora in GIT
  • Bacteria
    • Most common pathogen with bacteraemia identified in 10-25% of cases 
  • Fungal
    • Rarely cause first febrile episode 
    • Consider in high risk patients with persistent fever >5 days despite empiric antibiotics 
  • Viral
    • Effectively prevented with antiviral prophylaxis (i.e. valaciclovir 500mg daily) 

Non-infective (rare) [2]

  • Blood transfusion reaction 
  • Malignancy-related
  • Drug-induced 

Clinical Features  #

History [3, 4]

  • Localising symptoms of infection
  • PMHx
    • Type and staging of malignancy
    • High risk medical conditions {{Includes COPD, congestive cardiac failure, diabetes, poor functional status, malnutrition, oral/gastrointestinal mucositis, advanced age}}
    • Previous episodes of neutropenic sepsis
      • Nadir neutrophil count
      • Duration of neutropaenia
      • Source of infection
      • G-CSF requirements {{Granulocyte colony stimulating factor use (G-CSF) such as filgrastim}}
  • Chemotherapy history
    • Type(s) of chemotherapy {{High risk patients include induction chemotherapy for acute myeloid leukaemia and conditioning for allogeneic haematopoietic stem cell transplant}}
    • Date of most recent cycle
  • Drug history
    • Compliance with antifungal, antiviral and PJP prophylaxis {{pneumocystitis jirovecci pneumonia (PJP) prophylaxis}}
    • Steroids or G-CSF use
    • Allergies, especially to penicillin
  • Recent procedures  (surgical / invasive lines / bone marrow aspirates); note recent blood transfusion(s)
  • History of prior infection or colonisation (especially by antibiotic resistant organisms)

Examination [3, 4]

  • ABCDE approach if haemodynamically unstable
  • Thorough examination to look for source of infection
    • Mouth for ulcers or mucositis
    • Chest for pneumonia
    • Abdomen for neutropenic enterocolitis or other abdominal pathology 
    • Surgical sites for wound infections
    • Skin for cellulitis or skin lesions
    • Indwelling devices (PICC, ports, Hickmann’s, cannulas, urinary catheter + sites of previous lines)

Perianal inspection (if appropriate however, do NOT perform digital rectal examination)

Diagnosis #

Neutropenic Fever: [4,5]

Fever: ≥38.3°C OR two occasions of ≥38.0°C

AND

Neutropenia: neutrophils < 0.5 x109/L OR < 1.0 x109/L with predicted fall to < 0.5 x109/L

NOTE: Also treat empirically as febrile neutropenia if: [5]

  • If neutropenic  AND haemodynamically unstable WITHOUT fever
  • If febrile following chemotherapy  (and neutrophil count pending)

Investigations #

Initial investigations [3,4,5]

InvestigationsSignificance
Blood cultures x2Peripheral + central venous access catheter (CVAD) {{Can only be accessed by certain nursing staff}}OR peripheral x2 sites if no CVADDetect bacteraemia
FBECheck neutrophil count
VBGIf lactate >2.0, high risk of sepsis
*Urine MCS, CXR are done routinely (even if asymptomatic) in some hospitals – clarify with unit registrar if unsure 

Further investigations [3,4,5]

InvestigationsIndication
Bloods 
UEC, LFTsAs baseline if not already done as guides antibiotic doses and defines comorbidities
CMP, LDH, uric acid, coagulation studiesAs baseline if not already done or if concerned re: tumor lysis syndrome
CulturesIsolating the source {drop down box}
Urine MCS or urinalysis*If urinary symptoms or frequent urinary tract infections (UTI)
Stool MCS including Clostridium difficileIf diarrhoea
Skin swab for MCSIf purulent discharge from wound, surrounding CVAD site or skin lesion
Respiratory PCR& COVID swabIf respiratory symptoms
Imaging 
CXR*If respiratory symptoms or non-adherence to PJP/antifungal prophylaxis to rule out pneumonia/pulmonary infiltrate
#High resolution CT-chest +/- sinusesConsider if persistent fevers despite >5 days of empiric antibiotics or previous invasive fungal disease rule out invasive fungal disease or other pulmonary infiltrates
#CT abdomenIf diarrhoea or abdominal tenderness or pain, to rule out neutropenic enterocolitis

Referrals

Unit RegistrarDiscuss with home teamThis is a medical emergency as these patients deteriorate quicklyUrgent referral if any of: Patient’s first episode of febrile neutropeniaHaemodynamically unstableAny other clinical concerns/change
Infectious DiseasesConsider referral, especially if:Previous multi-drug resistant organisms or invasive fungal infectionCultures isolate organism to assist antibiotic rationalisation

Management [5,6,7] #

Please refer to local hospital protocol for preferred first line therapy – hospital policies can vary widely due to difference in local antimicrobial resistance patterns

Management – first fever & haemodynamically stable  [5,6,7] #

  • Antibiotics within 60 minutes (with x2 blood cultures prior)

WITHOUT septic shock and NOT requiring ICU support

Piperacillin + Tazobactam 4.5 g IV 6hrly OR Cefepime 2g IV 8 hrlyIf non-severe penicillin allergy: Cefepime 2g IV 8 hrlyIf severe penicillin allergy: Ciprofloxacin 400mg IV 12hrly AND Vancomycin IV loading dose {hyperlink to vancomycin dosing guideline} 

If features of abdominal or perineal infection AND NOT receiving piperacillin-tazobactam or meropenem 

ADD Metronidazole 500mg IV 12hrly 

If obvious vascular device infection OR cellulitis OR known to be colonised or recently infected with MRSA 

ADD Vancomycin IV {hyperlink to vancomycin dosing guideline} 

If known to be colonised or recently infected with multi-drug resistant gram negative bacteria (i.e. ESBL) 

Meropenem 1g IV 8 hrly instead of piperacillin-tazobactam or cefepime 

Management – first fever & haemodynamically unstable  [5,6,7] #

  • MET call
  • IV fluid resuscitation
  • Antibiotics within 30 minutes (with x2 blood cultures prior) 

WITH septic shock or requiring ICU support

Piperacillin + Tazobactam 4.5 g IV 6hrly OR Cefepime 2g IV 8 hrlyIf non-severe penicillin allergy: Cefepime 2g IV 8 hrlyIf severe penicillin allergy: Ciprofloxacin 400mg IV 12hrly AND Vancomycin IV loading dose ANDGentamicin IVIf kidney impairment 4-5mg/kg; otherwise 7mg/kg [6] ANDVancomycin 25-30mg/kg IV loading dose [6] If known to be colonised with VRE, consider empiric teicoplanin or linezolid. Discuss with ID 

 If features of abdominal or perineal infection AND NOT receiving piperacillin-tazobactam or meropenem 

ADD Metronidazole 500mg IV 12hrly 

If known to be colonised or recently infected with multi-drug resistant gram negative bacteria (i.e. ESBL) 

Meropenem 1g IV 8 hrly instead of piperacillin-tazobactam or cefepime 

Other considerations

  • Discuss with home team/infectious diseases re: empiric antifungal
  • If there is evidence of colonisation but other multidrug resistant organisms (e.g. Carbapenemase-Resistant Enterobacteraciae (CPE) or Vancomycin Resistant Enterococci (VRE)), seek early infectious diseases input

Management – subsequent fevers [5,7] #

  • Generally NO NEED TO CHANGE empiric IV antibiotics unless:
    • Haemodynamically unstable
    • New infective focus
    • Indicated by culture or imaging results
  • Repeat blood cultures
    • Advised if: ongoing fevers AND  >72hr of empiric antibiotics
    • Consider if: already 2 sets of cultures taken AND < 72hr of empiric antibiotics
  • If haemodynamically unstable
    • MET call + notify unit registrar
    • Repeat full septic screen
    • Add gentamicin and vancomycin (see above)
    • Consider discussing with ID re: empiric antifungal
    • Consider discussing with unit registrar re G-CSF
  • If in doubt, have a low threshold for contacting the home team registrar for advice

References #

  1. Bow E, Wingard J. Overview of neutropenic fever syndromes [Internet]. UpToDate. 2020 [cited 29 August 2021]. Available from: https://www.uptodate.com/contents/overview-of-neutropenic-fever-syndromes?search=febrile%20neutropenia&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
  2. Platt J. Neutropenic Sepsis [Internet]. Geeky Medics. 2020 [cited 29 August 2021]. Available from: https://geekymedics.com/neutropenic-sepsis/
  3. O’Brien J, Watson P. The Junior Doctor Survival Guide. 1st ed. Elsevier; 2017.
  4. Wingard J. Diagnostic approach to adult cancer patient with neutropenic fever [Internet]. UpToDate. 2020 [cited 29 August 2021]. Available from: https://www.uptodate.com/contents/diagnostic-approach-to-the-adult-cancer-patient-with-neutropenic-fever#H29410331 
  5. Tam C, O’Reilly M, Andresen D, Lingaratnam S, Kelly A, Burbury K et al. Use of empiric antimicrobial therapy in neutropenic fever. Internal Medicine Journal. 2011;41(1b):90-101.
  6. Kelly H et al. Febrile Neutropenia [Internet]. eTG Complete. 2019 [cited 29 August 2021]. Available from: https://tgldcdp.tg.org.au.acs.hcn.com.au/viewTopic?topicfile=febrile-neutropenia&guidelineName=Antibiotic&topicNavigation=navigateTopic#toc_d1e47
  7. Wingard J. Treatment of neutropenic fever syndromes in adults with hematologic malignancies and hematopoietic cell transplant recipients (high-risk patients) [Internet]. UpToDate. 2021 [cited 29 August 2021]. Available from: https://www.uptodate.com/contents/treatment-of-neutropenic-fever-syndromes-in-adults-with-hematologic-malignancies-and-hematopoietic-cell-transplant-recipients-high-risk-patients
  • Contributors

  • Reviewing Consultant/Senior Registrar

Dr Kate Drummond

Dr Adam Steinberg

What are your Feelings
Share This Article :
  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
Updated on March 27, 2023
Table of Contents
  • Overview
  • Triage
  • Causes
  • Clinical Features 
  • Diagnosis
  • Investigations
  • Management [5,6,7]
  • Management - first fever & haemodynamically stable  [5,6,7]
  • Management - first fever & haemodynamically unstable  [5,6,7]
  • Management - subsequent fevers [5,7]
  • References

Teaching for Impact

Our mission as a group of young leaders is to create positive and meaningful change in the community through education. We offer a variety of initiatives that empower different sectors of society to realize their full potential and use their skills, knowledge, and experience to enhance the lives of those in their surroundings.

Find us on socials

YouTube Facebook Twitter Instagram
  • Privacy Policy
  • Cookie Policy
  • Terms and conditions

Made with ♥ for the community